How does Carevive ensure data security?

In this video, Stan Norton, the Chief Technology Officer at Carevive, sheds light on the robust privacy measures implemented to protect patient data. At Carevive, patient privacy is of utmost importance, and the team is dedicated to upholding the highest standards.

To ensure compliance with federal regulations, the company conducts an annual HIPAA risk assessment. This comprehensive evaluation helps identify any potential gaps in their processes, enabling them to proactively address and mitigate risks.

Norton emphasizes the use of physical mechanisms, in accordance with HIPAA security rules, to securely store data in a high-trust, SOC 2 Type 2 certified cloud environment. Additionally, Carevive remains vigilant against cyberattacks, employing proper endpoint management to safeguard sensitive information.

With a long-standing commitment to data security and privacy, Carevive assures patients and partners that their data is handled with the utmost care and protection. The team welcomes any further discussions on their privacy measures and is always ready to provide more insights into their robust data protection practices.

Recent Episodes

In this episode of Inside Restoration & Recovery, host Martha Lewis welcomes Jason McClaren, Director of Facilities Operations at Reunion Rehabilitation Hospitals, to discuss the critical advantage of partnering with a restoration team experienced in healthcare. A former firefighter and military veteran, Jason has spent the last decade managing safety, risk, and emergency preparedness…

In this impactful episode of the ConCensis podcast, host Yasmeen Hassan sits down with Robby Miller, Sterile Processing Manager at St. Joseph’s Hospital Medical Center, to explore how artificial intelligence is revolutionizing the field of sterile processing. With nearly 30 years of experience in healthcare, Miller shares his journey from EMT to SPD leader, offering…

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…